Overview |
bsm-90040R |
MAP2K1 Recombinant Antbody Kit (KD-Validated) |
WB, FCM, IC |
Knockdown Validated |
Human, Mouse, Rat |
Specifications |
Unconjugated |
Rabbit |
A synthesized peptide derived from human MEK1 |
1-40/393 |
Monoclonal |
IgG |
Lot dependent |
Affinity Purified |
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
-20 °C |
Target |
5604 |
Q02750 |
MAP2K1; Mitogen-Activated Protein Kinase Kinase 1; MEK1; Dual Specificity Mitogen-Activated Protein Kinase Kinase 1; MAPK/ERK Kinase 1; MAPKK1; PRKMK1; MKK1; ERK Activator Kinase 1; MAP Kinase Kinase 1; EC 2.7.12.2; MAPKK 1; MEK 1; Protein Kinase Mitogen-Activated Kinase 1 (MAP Kinase Kinase 1); CFC3; MEL |
Cell Line: Hela Knockdown technology: shRNA Knockdown |
Application Dilution |
WB |
1:300-5000 |
FCM |
1:20-100 |
IC |
1:1000 |